

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | exogenous drug catabolic process (GO:0042738) | 6.87061076 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.85527456 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.85527456 |
| 4 | epoxygenase P450 pathway (GO:0019373) | 6.81846484 |
| 5 | omega-hydroxylase P450 pathway (GO:0097267) | 6.59972520 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 6.51508404 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.51508404 |
| 8 | regulation of plasminogen activation (GO:0010755) | 6.30354124 |
| 9 | aromatic amino acid family catabolic process (GO:0009074) | 6.26598869 |
| 10 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.20604467 |
| 11 | indole-containing compound catabolic process (GO:0042436) | 5.74894853 |
| 12 | indolalkylamine catabolic process (GO:0046218) | 5.74894853 |
| 13 | tryptophan catabolic process (GO:0006569) | 5.74894853 |
| 14 | kynurenine metabolic process (GO:0070189) | 5.59343013 |
| 15 | urea cycle (GO:0000050) | 5.57836207 |
| 16 | urea metabolic process (GO:0019627) | 5.57836207 |
| 17 | high-density lipoprotein particle remodeling (GO:0034375) | 5.54288622 |
| 18 | bile acid biosynthetic process (GO:0006699) | 5.52867002 |
| 19 | complement activation, alternative pathway (GO:0006957) | 5.45168328 |
| 20 | * peptidyl-glutamic acid carboxylation (GO:0017187) | 5.43582145 |
| 21 | * protein carboxylation (GO:0018214) | 5.43582145 |
| 22 | tryptophan metabolic process (GO:0006568) | 5.41162172 |
| 23 | negative regulation of fibrinolysis (GO:0051918) | 5.39118115 |
| 24 | glyoxylate metabolic process (GO:0046487) | 5.26677816 |
| 25 | regulation of protein activation cascade (GO:2000257) | 5.18734747 |
| 26 | alpha-linolenic acid metabolic process (GO:0036109) | 5.16246590 |
| 27 | regulation of fibrinolysis (GO:0051917) | 5.14406096 |
| 28 | nitrogen cycle metabolic process (GO:0071941) | 5.10930005 |
| 29 | negative regulation of blood coagulation (GO:0030195) | 4.96423970 |
| 30 | negative regulation of hemostasis (GO:1900047) | 4.96423970 |
| 31 | reverse cholesterol transport (GO:0043691) | 4.90768337 |
| 32 | regulation of cholesterol esterification (GO:0010872) | 4.89408799 |
| 33 | sulfur amino acid catabolic process (GO:0000098) | 4.89406492 |
| 34 | regulation of complement activation (GO:0030449) | 4.87049837 |
| 35 | drug metabolic process (GO:0017144) | 4.86605742 |
| 36 | plasma lipoprotein particle remodeling (GO:0034369) | 4.82161245 |
| 37 | protein-lipid complex remodeling (GO:0034368) | 4.82161245 |
| 38 | macromolecular complex remodeling (GO:0034367) | 4.82161245 |
| 39 | cysteine metabolic process (GO:0006534) | 4.78447011 |
| 40 | phospholipid efflux (GO:0033700) | 4.72178860 |
| 41 | bile acid metabolic process (GO:0008206) | 4.72051242 |
| 42 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.70224455 |
| 43 | ethanol metabolic process (GO:0006067) | 4.64885052 |
| 44 | regulation of humoral immune response (GO:0002920) | 4.64110812 |
| 45 | regulation of apoptotic cell clearance (GO:2000425) | 4.63310983 |
| 46 | oxidative demethylation (GO:0070989) | 4.59949549 |
| 47 | regulation of triglyceride catabolic process (GO:0010896) | 4.58193378 |
| 48 | plasma lipoprotein particle clearance (GO:0034381) | 4.55574201 |
| 49 | serine family amino acid catabolic process (GO:0009071) | 4.53773095 |
| 50 | intestinal cholesterol absorption (GO:0030299) | 4.52072755 |
| 51 | negative regulation of coagulation (GO:0050819) | 4.51228562 |
| 52 | aromatic amino acid family metabolic process (GO:0009072) | 4.49722315 |
| 53 | negative regulation of wound healing (GO:0061045) | 4.42107575 |
| 54 | homocysteine metabolic process (GO:0050667) | 4.40005649 |
| 55 | tyrosine metabolic process (GO:0006570) | 4.38131301 |
| 56 | phenylpropanoid metabolic process (GO:0009698) | 4.32684108 |
| 57 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 4.31555789 |
| 58 | cholesterol efflux (GO:0033344) | 4.31106870 |
| 59 | negative regulation of cholesterol transport (GO:0032375) | 4.30474940 |
| 60 | negative regulation of sterol transport (GO:0032372) | 4.30474940 |
| 61 | triglyceride homeostasis (GO:0070328) | 4.30261192 |
| 62 | acylglycerol homeostasis (GO:0055090) | 4.30261192 |
| 63 | aldehyde catabolic process (GO:0046185) | 4.28422297 |
| 64 | negative regulation of protein activation cascade (GO:2000258) | 4.26015598 |
| 65 | low-density lipoprotein particle remodeling (GO:0034374) | 4.24205270 |
| 66 | amino-acid betaine metabolic process (GO:0006577) | 4.19715370 |
| 67 | alpha-amino acid catabolic process (GO:1901606) | 4.15519110 |
| 68 | lysine metabolic process (GO:0006553) | 4.06005667 |
| 69 | lysine catabolic process (GO:0006554) | 4.06005667 |
| 70 | cellular glucuronidation (GO:0052695) | 4.03210766 |
| 71 | indolalkylamine metabolic process (GO:0006586) | 4.03024790 |
| 72 | fibrinolysis (GO:0042730) | 4.02910024 |
| 73 | * positive regulation of blood coagulation (GO:0030194) | 4.02025985 |
| 74 | * positive regulation of hemostasis (GO:1900048) | 4.02025985 |
| 75 | bile acid and bile salt transport (GO:0015721) | 4.00754642 |
| 76 | imidazole-containing compound metabolic process (GO:0052803) | 4.00209147 |
| 77 | amine catabolic process (GO:0009310) | 3.99910746 |
| 78 | cellular biogenic amine catabolic process (GO:0042402) | 3.99910746 |
| 79 | cellular ketone body metabolic process (GO:0046950) | 3.99909130 |
| 80 | phospholipid homeostasis (GO:0055091) | 3.94359175 |
| 81 | plasma lipoprotein particle assembly (GO:0034377) | 3.93775818 |
| 82 | coenzyme catabolic process (GO:0009109) | 3.89728647 |
| 83 | cytolysis (GO:0019835) | 3.88004914 |
| 84 | regulation of lipoprotein particle clearance (GO:0010984) | 3.85301868 |
| 85 | glycine metabolic process (GO:0006544) | 3.83975686 |
| 86 | benzene-containing compound metabolic process (GO:0042537) | 3.83081327 |
| 87 | S-adenosylmethionine metabolic process (GO:0046500) | 3.81196103 |
| 88 | cellular amino acid catabolic process (GO:0009063) | 3.79730633 |
| 89 | plasma lipoprotein particle organization (GO:0071827) | 3.78182210 |
| 90 | proline metabolic process (GO:0006560) | 3.78166603 |
| 91 | arginine metabolic process (GO:0006525) | 3.77760695 |
| 92 | cofactor catabolic process (GO:0051187) | 3.76859616 |
| 93 | acute-phase response (GO:0006953) | 3.76036401 |
| 94 | glutamate metabolic process (GO:0006536) | 3.75880654 |
| 95 | positive regulation of lipid catabolic process (GO:0050996) | 3.74183510 |
| 96 | blood coagulation, intrinsic pathway (GO:0007597) | 3.74086370 |
| 97 | uronic acid metabolic process (GO:0006063) | 3.71647205 |
| 98 | glucuronate metabolic process (GO:0019585) | 3.71647205 |
| 99 | cellular modified amino acid catabolic process (GO:0042219) | 3.70711893 |
| 100 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.69933213 |
| 101 | complement activation (GO:0006956) | 3.69061763 |
| 102 | ethanol oxidation (GO:0006069) | 3.68984815 |
| 103 | * positive regulation of coagulation (GO:0050820) | 3.66969246 |
| 104 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.66498031 |
| 105 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.66498031 |
| 106 | opsonization (GO:0008228) | 3.64573761 |
| 107 | * protein activation cascade (GO:0072376) | 3.64415103 |
| 108 | cholesterol homeostasis (GO:0042632) | 3.63998179 |
| 109 | acute inflammatory response (GO:0002526) | 3.62541497 |
| 110 | serine family amino acid metabolic process (GO:0009069) | 3.61484740 |
| 111 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.60565647 |
| 112 | negative regulation of lipid transport (GO:0032369) | 3.59350794 |
| 113 | complement activation, classical pathway (GO:0006958) | 3.59333866 |
| 114 | alkaloid metabolic process (GO:0009820) | 3.59204976 |
| 115 | sterol homeostasis (GO:0055092) | 3.58636606 |
| 116 | protein-lipid complex subunit organization (GO:0071825) | 3.56851932 |
| 117 | drug catabolic process (GO:0042737) | 3.56116426 |
| 118 | protein-lipid complex assembly (GO:0065005) | 3.55307716 |
| 119 | negative regulation of complement activation (GO:0045916) | 3.53058611 |
| 120 | NAD biosynthetic process (GO:0009435) | 3.49631375 |
| 121 | lipoprotein metabolic process (GO:0042157) | 3.47809563 |
| 122 | regulation of cholesterol homeostasis (GO:2000188) | 3.47766686 |
| 123 | negative regulation of lipase activity (GO:0060192) | 3.47096787 |
| 124 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.45928161 |
| 125 | ketone body metabolic process (GO:1902224) | 3.43984028 |
| 126 | serine family amino acid biosynthetic process (GO:0009070) | 3.42048048 |
| 127 | sterol transport (GO:0015918) | 3.40640388 |
| 128 | cholesterol transport (GO:0030301) | 3.40640388 |
| 129 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.39956465 |
| 130 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.39956465 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.67020629 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.61319695 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.40058752 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.98582541 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.92837806 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.70518177 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.50750488 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.66896218 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.61099553 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.70836923 |
| 11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.35642137 |
| 12 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.9037312 |
| 13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.99409429 |
| 14 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.98126378 |
| 15 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.91853102 |
| 16 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.89276950 |
| 17 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.83993165 |
| 18 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.75822558 |
| 19 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.70945716 |
| 20 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.64573435 |
| 21 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.59593394 |
| 22 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.54132250 |
| 23 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.49272223 |
| 24 | GATA1_22025678_ChIP-Seq_K562_Human | 1.47902462 |
| 25 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.47404605 |
| 26 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.45234799 |
| 27 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.41552757 |
| 28 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.39354559 |
| 29 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.35941473 |
| 30 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.34843827 |
| 31 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.25186812 |
| 32 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.23444984 |
| 33 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.22131436 |
| 34 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.16474524 |
| 35 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.11630266 |
| 36 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.08534988 |
| 37 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.05658155 |
| 38 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.01713336 |
| 39 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.01445135 |
| 40 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.99969985 |
| 41 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.98981643 |
| 42 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.98201853 |
| 43 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.95707731 |
| 44 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.95029910 |
| 45 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.94477969 |
| 46 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.94349340 |
| 47 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89772660 |
| 48 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.88539022 |
| 49 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.88404018 |
| 50 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.87850141 |
| 51 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.87399199 |
| 52 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.85669253 |
| 53 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.84249008 |
| 54 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.79710992 |
| 55 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.79160814 |
| 56 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.78932560 |
| 57 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.78864450 |
| 58 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.77592033 |
| 59 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.77394252 |
| 60 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.76539422 |
| 61 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.76296749 |
| 62 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.76296749 |
| 63 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.75895683 |
| 64 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.74838423 |
| 65 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.73828114 |
| 66 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.72759317 |
| 67 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.72154870 |
| 68 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.71905620 |
| 69 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.71086296 |
| 70 | P68_20966046_ChIP-Seq_HELA_Human | 0.70476773 |
| 71 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.70455748 |
| 72 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.69990418 |
| 73 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.69891793 |
| 74 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.69383608 |
| 75 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.68811182 |
| 76 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.68777582 |
| 77 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.67921101 |
| 78 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.67169863 |
| 79 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.66622077 |
| 80 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.66535621 |
| 81 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.65385467 |
| 82 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.65329887 |
| 83 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.65015479 |
| 84 | SA1_27219007_Chip-Seq_Bcells_Human | 0.63539887 |
| 85 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.63006569 |
| 86 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.62925127 |
| 87 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.62838724 |
| 88 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.62208484 |
| 89 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.61833886 |
| 90 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.61157577 |
| 91 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.61006137 |
| 92 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.60990978 |
| 93 | GATA2_19941826_ChIP-Seq_K562_Human | 0.60797535 |
| 94 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.60263660 |
| 95 | GATA1_19941826_ChIP-Seq_K562_Human | 0.60110322 |
| 96 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.59675753 |
| 97 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.59380824 |
| 98 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.59228386 |
| 99 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.57892686 |
| 100 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.57717860 |
| 101 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.57102304 |
| 102 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.57046841 |
| 103 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.56830111 |
| 104 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.56571482 |
| 105 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.56117029 |
| 106 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.56059677 |
| 107 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.55612833 |
| 108 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.55450937 |
| 109 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.55417355 |
| 110 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.55252267 |
| 111 | * NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.55113264 |
| 112 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.54949010 |
| 113 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.54331440 |
| 114 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.54110270 |
| 115 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.53997712 |
| 116 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.53813423 |
| 117 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.53497921 |
| 118 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.52519773 |
| 119 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.52396119 |
| 120 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.52099657 |
| 121 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.51816293 |
| 122 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.51642142 |
| 123 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.51639057 |
| 124 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.51508649 |
| 125 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.51284759 |
| 126 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.48763022 |
| 127 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.48267543 |
| 128 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.48222565 |
| 129 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.47953292 |
| 130 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.47176314 |
| 131 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.47044859 |
| 132 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.46702156 |
| 133 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.46549205 |
| 134 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.46219837 |
| 135 | * CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.46181693 |
| 136 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.46108160 |
| 137 | * MYC_19915707_ChIP-ChIP_AK7_Human | 0.45863587 |
| 138 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.45521076 |
| 139 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.45339978 |
| 140 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.44667518 |
| 141 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.44378517 |
| 142 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.44060363 |
| 143 | AR_20517297_ChIP-Seq_VCAP_Human | 0.43796907 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.42180769 |
| 2 | MP0005360_urolithiasis | 6.85542322 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.65414192 |
| 4 | MP0005365_abnormal_bile_salt | 5.45748875 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.59813865 |
| 6 | MP0009840_abnormal_foam_cell | 3.88625276 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.70802399 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.45827628 |
| 9 | MP0003252_abnormal_bile_duct | 3.35840514 |
| 10 | MP0005083_abnormal_biliary_tract | 3.05061866 |
| 11 | MP0003191_abnormal_cellular_cholesterol | 3.00439126 |
| 12 | MP0003195_calcinosis | 2.65426431 |
| 13 | MP0005332_abnormal_amino_acid | 2.49410587 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.23422526 |
| 15 | MP0000609_abnormal_liver_physiology | 2.12438193 |
| 16 | MP0002118_abnormal_lipid_homeostasis | 2.02558672 |
| 17 | MP0004019_abnormal_vitamin_homeostasis | 1.96983612 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 1.96846596 |
| 19 | MP0005319_abnormal_enzyme/_coenzyme | 1.83124988 |
| 20 | MP0005451_abnormal_body_composition | 1.69087496 |
| 21 | MP0000566_synostosis | 1.68818865 |
| 22 | MP0003436_decreased_susceptibility_to | 1.64285331 |
| 23 | MP0001764_abnormal_homeostasis | 1.54158421 |
| 24 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.53701809 |
| 25 | MP0003868_abnormal_feces_composition | 1.49930028 |
| 26 | MP0003011_delayed_dark_adaptation | 1.46542957 |
| 27 | MP0009764_decreased_sensitivity_to | 1.46024452 |
| 28 | MP0000604_amyloidosis | 1.44186185 |
| 29 | MP0003186_abnormal_redox_activity | 1.38251510 |
| 30 | MP0003705_abnormal_hypodermis_morpholog | 1.35709687 |
| 31 | MP0003724_increased_susceptibility_to | 1.35339958 |
| 32 | MP0005058_abnormal_lysosome_morphology | 1.33899628 |
| 33 | MP0003656_abnormal_erythrocyte_physiolo | 1.30988685 |
| 34 | MP0009697_abnormal_copulation | 1.27718721 |
| 35 | * MP0008469_abnormal_protein_level | 1.27588425 |
| 36 | MP0002132_abnormal_respiratory_system | 1.21894752 |
| 37 | MP0009763_increased_sensitivity_to | 1.21156712 |
| 38 | MP0000598_abnormal_liver_morphology | 1.21107586 |
| 39 | MP0003122_maternal_imprinting | 1.20478211 |
| 40 | MP0006082_CNS_inflammation | 1.19039042 |
| 41 | MP0009643_abnormal_urine_homeostasis | 1.18546488 |
| 42 | MP0005464_abnormal_platelet_physiology | 1.15812826 |
| 43 | MP0001835_abnormal_antigen_presentation | 1.13380774 |
| 44 | MP0002419_abnormal_innate_immunity | 1.08828971 |
| 45 | MP0003690_abnormal_glial_cell | 1.07321822 |
| 46 | MP0001915_intracranial_hemorrhage | 1.05292937 |
| 47 | MP0002254_reproductive_system_inflammat | 1.02685680 |
| 48 | MP0003879_abnormal_hair_cell | 0.97130580 |
| 49 | MP0009785_altered_susceptibility_to | 0.97042565 |
| 50 | MP0005647_abnormal_sex_gland | 0.95707668 |
| 51 | MP0003075_altered_response_to | 0.95642560 |
| 52 | MP0005025_abnormal_response_to | 0.91986420 |
| 53 | MP0003303_peritoneal_inflammation | 0.91880370 |
| 54 | MP0009642_abnormal_blood_homeostasis | 0.91043510 |
| 55 | MP0004782_abnormal_surfactant_physiolog | 0.90898263 |
| 56 | MP0005670_abnormal_white_adipose | 0.87826601 |
| 57 | MP0002971_abnormal_brown_adipose | 0.85860685 |
| 58 | MP0005408_hypopigmentation | 0.84098520 |
| 59 | MP0002249_abnormal_larynx_morphology | 0.82866751 |
| 60 | MP0004130_abnormal_muscle_cell | 0.82607101 |
| 61 | MP0005636_abnormal_mineral_homeostasis | 0.81308053 |
| 62 | MP0002089_abnormal_postnatal_growth/wei | 0.81137103 |
| 63 | MP0001845_abnormal_inflammatory_respons | 0.78788769 |
| 64 | MP0005334_abnormal_fat_pad | 0.77672062 |
| 65 | MP0002282_abnormal_trachea_morphology | 0.77492929 |
| 66 | MP0005166_decreased_susceptibility_to | 0.76831336 |
| 67 | MP0005376_homeostasis/metabolism_phenot | 0.75324380 |
| 68 | MP0009765_abnormal_xenobiotic_induced | 0.73364217 |
| 69 | MP0005395_other_phenotype | 0.72990101 |
| 70 | MP0005535_abnormal_body_temperature | 0.70623457 |
| 71 | MP0001533_abnormal_skeleton_physiology | 0.70246166 |
| 72 | MP0003172_abnormal_lysosome_physiology | 0.69886972 |
| 73 | MP0001853_heart_inflammation | 0.69317005 |
| 74 | MP0002078_abnormal_glucose_homeostasis | 0.69236050 |
| 75 | MP0002168_other_aberrant_phenotype | 0.69153653 |
| 76 | MP0005387_immune_system_phenotype | 0.67706705 |
| 77 | MP0001790_abnormal_immune_system | 0.67706705 |
| 78 | MP0003329_amyloid_beta_deposits | 0.67137623 |
| 79 | MP0010368_abnormal_lymphatic_system | 0.66833069 |
| 80 | MP0004947_skin_inflammation | 0.65170036 |
| 81 | MP0002148_abnormal_hypersensitivity_rea | 0.64398046 |
| 82 | MP0005000_abnormal_immune_tolerance | 0.63022019 |
| 83 | MP0004510_myositis | 0.62289183 |
| 84 | MP0005448_abnormal_energy_balance | 0.61608466 |
| 85 | MP0006036_abnormal_mitochondrial_physio | 0.61025809 |
| 86 | MP0008873_increased_physiological_sensi | 0.58269243 |
| 87 | MP0002136_abnormal_kidney_physiology | 0.57497718 |
| 88 | MP0001756_abnormal_urination | 0.57111766 |
| 89 | MP0001800_abnormal_humoral_immune | 0.55669446 |
| 90 | MP0000685_abnormal_immune_system | 0.55655107 |
| 91 | MP0005084_abnormal_gallbladder_morpholo | 0.55084764 |
| 92 | MP0002876_abnormal_thyroid_physiology | 0.54403215 |
| 93 | MP0002723_abnormal_immune_serum | 0.53122462 |
| 94 | MP0000249_abnormal_blood_vessel | 0.53087019 |
| 95 | MP0002909_abnormal_adrenal_gland | 0.52096336 |
| 96 | MP0005220_abnormal_exocrine_pancreas | 0.51066354 |
| 97 | MP0001661_extended_life_span | 0.50721336 |
| 98 | MP0009115_abnormal_fat_cell | 0.50691873 |
| 99 | MP0008872_abnormal_physiological_respon | 0.50260902 |
| 100 | MP0009053_abnormal_anal_canal | 0.50090132 |
| 101 | MP0005164_abnormal_response_to | 0.49906683 |
| 102 | MP0005248_abnormal_Harderian_gland | 0.49773567 |
| 103 | MP0003638_abnormal_response/metabolism_ | 0.49689790 |
| 104 | MP0002452_abnormal_antigen_presenting | 0.49563206 |
| 105 | MP0004883_abnormal_blood_vessel | 0.48710080 |
| 106 | MP0003300_gastrointestinal_ulcer | 0.48192091 |
| 107 | MP0001881_abnormal_mammary_gland | 0.46675655 |
| 108 | MP0000639_abnormal_adrenal_gland | 0.46206285 |
| 109 | MP0005187_abnormal_penis_morphology | 0.46183824 |
| 110 | MP0005266_abnormal_metabolism | 0.45532635 |
| 111 | MP0005409_darkened_coat_color | 0.44553756 |
| 112 | MP0000343_altered_response_to | 0.44380301 |
| 113 | MP0005023_abnormal_wound_healing | 0.44226536 |
| 114 | MP0002090_abnormal_vision | 0.43668209 |
| 115 | MP0008874_decreased_physiological_sensi | 0.43491203 |
| 116 | MP0009780_abnormal_chondrocyte_physiolo | 0.42780967 |
| 117 | MP0003878_abnormal_ear_physiology | 0.42504145 |
| 118 | MP0005377_hearing/vestibular/ear_phenot | 0.42504145 |
| 119 | MP0000003_abnormal_adipose_tissue | 0.41681399 |
| 120 | MP0004272_abnormal_basement_membrane | 0.40158746 |
| 121 | MP0004264_abnormal_extraembryonic_tissu | 0.39385879 |
| 122 | MP0003953_abnormal_hormone_level | 0.38594019 |
| 123 | MP0002970_abnormal_white_adipose | 0.36047302 |
| 124 | MP0005646_abnormal_pituitary_gland | 0.31906746 |
| 125 | MP0005167_abnormal_blood-brain_barrier | 0.30420086 |
| 126 | MP0005379_endocrine/exocrine_gland_phen | 0.30261254 |
| 127 | MP0000467_abnormal_esophagus_morphology | 0.29112579 |
| 128 | MP0003718_maternal_effect | 0.28666847 |
| 129 | MP0005375_adipose_tissue_phenotype | 0.27034001 |
| 130 | MP0009384_cardiac_valve_regurgitation | 0.26943620 |
| 131 | MP0003632_abnormal_nervous_system | 0.25953882 |
| 132 | MP0001944_abnormal_pancreas_morphology | 0.24362514 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.21453147 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.67792804 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 6.52654684 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 6.42535527 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.20289813 |
| 6 | Xanthomatosis (HP:0000991) | 6.00801463 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 5.62741114 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.24971696 |
| 9 | Complement deficiency (HP:0004431) | 5.24169271 |
| 10 | * Joint hemorrhage (HP:0005261) | 4.94237992 |
| 11 | Abnormality of the common coagulation pathway (HP:0010990) | 4.54256894 |
| 12 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.42786245 |
| 13 | Hypolipoproteinemia (HP:0010981) | 4.34225540 |
| 14 | Epidermoid cyst (HP:0200040) | 4.26343703 |
| 15 | Hyperammonemia (HP:0001987) | 4.12337691 |
| 16 | Abnormality of complement system (HP:0005339) | 4.10485622 |
| 17 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.06036679 |
| 18 | Hypoalphalipoproteinemia (HP:0003233) | 3.94428678 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.85969445 |
| 20 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.85155246 |
| 21 | Fat malabsorption (HP:0002630) | 3.78844226 |
| 22 | Systemic lupus erythematosus (HP:0002725) | 3.78111561 |
| 23 | Abnormality of methionine metabolism (HP:0010901) | 3.75650899 |
| 24 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.74155477 |
| 25 | Ketosis (HP:0001946) | 3.72848533 |
| 26 | Hyperglycinemia (HP:0002154) | 3.70037078 |
| 27 | Hypercholesterolemia (HP:0003124) | 3.68246187 |
| 28 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.57988999 |
| 29 | Abnormality of the intrinsic pathway (HP:0010989) | 3.47491161 |
| 30 | Myocardial infarction (HP:0001658) | 3.47105354 |
| 31 | Conjugated hyperbilirubinemia (HP:0002908) | 3.34653228 |
| 32 | Hyperglycinuria (HP:0003108) | 3.33409279 |
| 33 | Hypoglycemic coma (HP:0001325) | 3.33223767 |
| 34 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.30971613 |
| 35 | Abnormality of glycine metabolism (HP:0010895) | 3.30971613 |
| 36 | Glomerulonephritis (HP:0000099) | 3.07364817 |
| 37 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.01438398 |
| 38 | Hyperbilirubinemia (HP:0002904) | 3.00558440 |
| 39 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.00129535 |
| 40 | Steatorrhea (HP:0002570) | 2.95848904 |
| 41 | Abnormality of nucleobase metabolism (HP:0010932) | 2.94917753 |
| 42 | Spontaneous abortion (HP:0005268) | 2.82919337 |
| 43 | Gingival bleeding (HP:0000225) | 2.81411099 |
| 44 | Skin nodule (HP:0200036) | 2.80144658 |
| 45 | Hepatocellular carcinoma (HP:0001402) | 2.74016655 |
| 46 | Amyloidosis (HP:0011034) | 2.67000936 |
| 47 | Delayed CNS myelination (HP:0002188) | 2.59192244 |
| 48 | Eczematoid dermatitis (HP:0000976) | 2.57728722 |
| 49 | Vascular calcification (HP:0004934) | 2.57019863 |
| 50 | Mitral stenosis (HP:0001718) | 2.56017926 |
| 51 | Abnormality of purine metabolism (HP:0004352) | 2.55298891 |
| 52 | Ketoacidosis (HP:0001993) | 2.53368530 |
| 53 | Abnormality of serum amino acid levels (HP:0003112) | 2.52126148 |
| 54 | Rickets (HP:0002748) | 2.47985629 |
| 55 | Hypochromic microcytic anemia (HP:0004840) | 2.41013889 |
| 56 | Esophageal varix (HP:0002040) | 2.39185942 |
| 57 | Spastic diplegia (HP:0001264) | 2.37850857 |
| 58 | Osteomalacia (HP:0002749) | 2.36546713 |
| 59 | Metabolic acidosis (HP:0001942) | 2.35840174 |
| 60 | Hemorrhage of the eye (HP:0011885) | 2.31169400 |
| 61 | Thrombophlebitis (HP:0004418) | 2.29135568 |
| 62 | Cardiovascular calcification (HP:0011915) | 2.25988464 |
| 63 | Abnormal gallbladder morphology (HP:0012437) | 2.24699766 |
| 64 | Abnormality of the Achilles tendon (HP:0005109) | 2.23528943 |
| 65 | Hypophosphatemic rickets (HP:0004912) | 2.22559252 |
| 66 | Nephritis (HP:0000123) | 2.21995801 |
| 67 | Sensorimotor neuropathy (HP:0007141) | 2.20293542 |
| 68 | Cholelithiasis (HP:0001081) | 2.20005009 |
| 69 | Dicarboxylic aciduria (HP:0003215) | 2.19503940 |
| 70 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.19503940 |
| 71 | Axonal loss (HP:0003447) | 2.18956672 |
| 72 | Recurrent bacterial skin infections (HP:0005406) | 2.16554494 |
| 73 | Pancreatitis (HP:0001733) | 2.15675504 |
| 74 | * Menorrhagia (HP:0000132) | 2.15519564 |
| 75 | Irritability (HP:0000737) | 2.14880963 |
| 76 | Lethargy (HP:0001254) | 2.13198312 |
| 77 | Arthropathy (HP:0003040) | 2.09443562 |
| 78 | Hypoglycemic seizures (HP:0002173) | 2.08793291 |
| 79 | Acanthocytosis (HP:0001927) | 2.08541139 |
| 80 | Pulmonary embolism (HP:0002204) | 2.07129659 |
| 81 | Enlarged kidneys (HP:0000105) | 2.05692373 |
| 82 | Neonatal onset (HP:0003623) | 2.05595039 |
| 83 | Bifid scrotum (HP:0000048) | 2.03642487 |
| 84 | Abnormality of iron homeostasis (HP:0011031) | 2.03205520 |
| 85 | Fair hair (HP:0002286) | 2.01286894 |
| 86 | Abnormal gallbladder physiology (HP:0012438) | 1.99065480 |
| 87 | Cholecystitis (HP:0001082) | 1.99065480 |
| 88 | Vacuolated lymphocytes (HP:0001922) | 1.96083273 |
| 89 | Upper motor neuron abnormality (HP:0002127) | 1.93958029 |
| 90 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.92923295 |
| 91 | Gout (HP:0001997) | 1.92531236 |
| 92 | Opisthotonus (HP:0002179) | 1.92221413 |
| 93 | Cerebral edema (HP:0002181) | 1.91400567 |
| 94 | Malnutrition (HP:0004395) | 1.88622510 |
| 95 | Gangrene (HP:0100758) | 1.86456181 |
| 96 | Late onset (HP:0003584) | 1.85483089 |
| 97 | Nausea (HP:0002018) | 1.85083682 |
| 98 | Generalized aminoaciduria (HP:0002909) | 1.83994332 |
| 99 | Vomiting (HP:0002013) | 1.83874868 |
| 100 | Abnormality of the gallbladder (HP:0005264) | 1.82449520 |
| 101 | Abnormality of proline metabolism (HP:0010907) | 1.81781655 |
| 102 | Hydroxyprolinuria (HP:0003080) | 1.81781655 |
| 103 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.78949366 |
| 104 | Joint swelling (HP:0001386) | 1.76138243 |
| 105 | Increased serum ferritin (HP:0003281) | 1.74925480 |
| 106 | Brushfield spots (HP:0001088) | 1.73677880 |
| 107 | Purpura (HP:0000979) | 1.73257635 |
| 108 | Poikilocytosis (HP:0004447) | 1.72991061 |
| 109 | Recurrent skin infections (HP:0001581) | 1.72989629 |
| 110 | Neonatal hypoglycemia (HP:0001998) | 1.71110519 |
| 111 | Asymmetry of the thorax (HP:0001555) | 1.71050025 |
| 112 | Potter facies (HP:0002009) | 1.67444377 |
| 113 | Facial shape deformation (HP:0011334) | 1.67444377 |
| 114 | Reduced antithrombin III activity (HP:0001976) | 1.66922607 |
| 115 | Elevated alkaline phosphatase (HP:0003155) | 1.63244157 |
| 116 | Hyperphosphaturia (HP:0003109) | 1.58857226 |
| 117 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.56435035 |
| 118 | Reticulocytosis (HP:0001923) | 1.51821772 |
| 119 | Abnormality of vitamin metabolism (HP:0100508) | 1.50721356 |
| 120 | Hypertriglyceridemia (HP:0002155) | 1.48042683 |
| 121 | Glycosuria (HP:0003076) | 1.44819787 |
| 122 | Abnormality of urine glucose concentration (HP:0011016) | 1.44819787 |
| 123 | Retinal atrophy (HP:0001105) | 1.44242511 |
| 124 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.43780026 |
| 125 | Mucopolysacchariduria (HP:0008155) | 1.43780026 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 4.84993122 |
| 2 | ERN1 | 4.80318384 |
| 3 | FGFR4 | 3.67677400 |
| 4 | SIK1 | 3.39634951 |
| 5 | TAOK3 | 3.28813469 |
| 6 | ICK | 2.90575197 |
| 7 | TYK2 | 2.68836148 |
| 8 | PKN2 | 2.39507790 |
| 9 | MST1R | 2.30164580 |
| 10 | NTRK3 | 2.29359244 |
| 11 | TRIB3 | 2.24121150 |
| 12 | MAP3K14 | 2.24048025 |
| 13 | MAP4K1 | 2.21087092 |
| 14 | FGFR2 | 2.13924974 |
| 15 | TBK1 | 2.12880639 |
| 16 | ABL2 | 2.07372769 |
| 17 | PIK3CA | 2.07281042 |
| 18 | INSRR | 2.02420863 |
| 19 | BLK | 1.98767441 |
| 20 | ERBB4 | 1.97306201 |
| 21 | WNK4 | 1.95728376 |
| 22 | IRAK3 | 1.90566671 |
| 23 | NEK9 | 1.89019737 |
| 24 | DAPK2 | 1.66876755 |
| 25 | JAK1 | 1.60289770 |
| 26 | MAP2K4 | 1.58089724 |
| 27 | EPHB1 | 1.56457891 |
| 28 | CDK12 | 1.52448667 |
| 29 | JAK2 | 1.50433780 |
| 30 | FLT3 | 1.45445939 |
| 31 | PIK3CG | 1.41710972 |
| 32 | PTK6 | 1.39778931 |
| 33 | CSK | 1.33977578 |
| 34 | PDGFRA | 1.33756269 |
| 35 | MAPK11 | 1.31020486 |
| 36 | IKBKE | 1.26194596 |
| 37 | RIPK4 | 1.25932884 |
| 38 | IRAK4 | 1.23918016 |
| 39 | FGFR1 | 1.21999956 |
| 40 | PBK | 1.20359556 |
| 41 | GRK6 | 1.17023057 |
| 42 | TGFBR2 | 1.12659139 |
| 43 | KIT | 1.11163448 |
| 44 | MAP2K3 | 1.11031513 |
| 45 | MAP3K10 | 1.10473119 |
| 46 | RET | 1.05428474 |
| 47 | RIPK1 | 1.04496625 |
| 48 | CSF1R | 1.01747214 |
| 49 | EPHA3 | 0.99750584 |
| 50 | CAMK1D | 0.99346779 |
| 51 | SIK2 | 0.99125389 |
| 52 | KDR | 0.99081635 |
| 53 | PRKCG | 0.98836705 |
| 54 | PRKAA1 | 0.97295611 |
| 55 | EPHA4 | 0.96263508 |
| 56 | TYRO3 | 0.94820134 |
| 57 | BMX | 0.92578496 |
| 58 | MAPK4 | 0.92391805 |
| 59 | IKBKB | 0.89522350 |
| 60 | MAP3K11 | 0.86942622 |
| 61 | MAP3K13 | 0.86454781 |
| 62 | CDK6 | 0.86439016 |
| 63 | SGK494 | 0.80866462 |
| 64 | SGK223 | 0.80866462 |
| 65 | AKT3 | 0.80341201 |
| 66 | MAP2K6 | 0.76701331 |
| 67 | MAP3K2 | 0.76344497 |
| 68 | JAK3 | 0.74519642 |
| 69 | MTOR | 0.72863382 |
| 70 | ZAP70 | 0.71873072 |
| 71 | ERBB2 | 0.70064627 |
| 72 | MAP3K7 | 0.67993408 |
| 73 | EPHA2 | 0.67894286 |
| 74 | SMG1 | 0.67891429 |
| 75 | SGK1 | 0.66737143 |
| 76 | PRKAA2 | 0.66394228 |
| 77 | TNK2 | 0.66149918 |
| 78 | PRPF4B | 0.66111863 |
| 79 | BTK | 0.65961253 |
| 80 | DDR2 | 0.65786169 |
| 81 | MET | 0.65628890 |
| 82 | PRKCQ | 0.65548655 |
| 83 | MAPK12 | 0.64618813 |
| 84 | HCK | 0.64086645 |
| 85 | FGFR3 | 0.62565890 |
| 86 | PDPK1 | 0.60279313 |
| 87 | PRKCZ | 0.60251828 |
| 88 | PRKACG | 0.59972589 |
| 89 | PINK1 | 0.58765991 |
| 90 | MATK | 0.58340113 |
| 91 | MAP3K3 | 0.58146748 |
| 92 | SYK | 0.57710695 |
| 93 | WNK1 | 0.57549422 |
| 94 | LYN | 0.56569692 |
| 95 | GSK3A | 0.56509312 |
| 96 | MUSK | 0.55649486 |
| 97 | CSNK1D | 0.55339473 |
| 98 | FRK | 0.55236058 |
| 99 | RPS6KA6 | 0.54855522 |
| 100 | EGFR | 0.54324236 |
| 101 | RPS6KC1 | 0.53637467 |
| 102 | RPS6KL1 | 0.53637467 |
| 103 | PDK2 | 0.53468133 |
| 104 | PRKG1 | 0.53135680 |
| 105 | PRKACA | 0.52263146 |
| 106 | FGR | 0.49883261 |
| 107 | CAMK2G | 0.49717923 |
| 108 | CSNK1E | 0.48875108 |
| 109 | NLK | 0.48260420 |
| 110 | ABL1 | 0.47853848 |
| 111 | MAP3K5 | 0.47358488 |
| 112 | EEF2K | 0.46193039 |
| 113 | SGK2 | 0.46069370 |
| 114 | SRC | 0.45466794 |
| 115 | PDK1 | 0.45258071 |
| 116 | CHUK | 0.45193210 |
| 117 | RPS6KA3 | 0.44448717 |
| 118 | MARK2 | 0.44130867 |
| 119 | CDC42BPA | 0.43909928 |
| 120 | IRAK1 | 0.43762969 |
| 121 | IGF1R | 0.42482071 |
| 122 | MAPKAPK3 | 0.42219264 |
| 123 | MAPK7 | 0.41827886 |
| 124 | CAMK1G | 0.41565153 |
| 125 | LATS1 | 0.40259758 |
| 126 | MAP3K1 | 0.39949261 |
| 127 | CDK4 | 0.38983928 |
| 128 | STK38 | 0.38913210 |
| 129 | PRKCD | 0.37932695 |
| 130 | FES | 0.37578555 |
| 131 | SGK3 | 0.36274394 |
| 132 | CDK7 | 0.36063213 |
| 133 | MAPK3 | 0.35395312 |
| 134 | TAOK2 | 0.34380216 |
| 135 | IRAK2 | 0.34210419 |
| 136 | DYRK1B | 0.34051629 |
| 137 | TXK | 0.33522266 |
| 138 | RPS6KB1 | 0.33393037 |
| 139 | MAPK15 | 0.33317820 |
| 140 | CSNK2A1 | 0.33049677 |
| 141 | STK10 | 0.32632877 |
| 142 | CAMKK1 | 0.32584622 |
| 143 | MARK3 | 0.32564870 |
| 144 | MAP2K2 | 0.32333942 |
| 145 | PTK2 | 0.31338391 |
| 146 | FER | 0.30838254 |
| 147 | CSNK2A2 | 0.30798460 |
| 148 | PRKCB | 0.30789284 |
| 149 | NTRK1 | 0.30120346 |
| 150 | PRKCH | 0.29804602 |
| 151 | PIM1 | 0.29200029 |
| 152 | LCK | 0.28956739 |
| 153 | MAP2K1 | 0.28955966 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.54052705 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.48397467 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.40573723 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.26103691 |
| 5 | * Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.10701697 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.08124776 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.58330345 |
| 8 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.57102923 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.54890046 |
| 10 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.46725265 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.39796851 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.36635831 |
| 13 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.36278873 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.19598918 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.10822588 |
| 16 | Histidine metabolism_Homo sapiens_hsa00340 | 2.03628088 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 2.02574927 |
| 18 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.93360910 |
| 19 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.92254297 |
| 20 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.91055058 |
| 21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.90845959 |
| 22 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.89389869 |
| 23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.88937498 |
| 24 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.79582825 |
| 25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.71408444 |
| 26 | Retinol metabolism_Homo sapiens_hsa00830 | 1.65702503 |
| 27 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.65635459 |
| 28 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.64759972 |
| 29 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.54814793 |
| 30 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.54123422 |
| 31 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.48662655 |
| 32 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.45572742 |
| 33 | Bile secretion_Homo sapiens_hsa04976 | 1.41449438 |
| 34 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.38077974 |
| 35 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.36524919 |
| 36 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.34087446 |
| 37 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.32463528 |
| 38 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.29561496 |
| 39 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.28997586 |
| 40 | ABC transporters_Homo sapiens_hsa02010 | 1.26859356 |
| 41 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.19312298 |
| 42 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.16495989 |
| 43 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.15859402 |
| 44 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.11987779 |
| 45 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.11092846 |
| 46 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.08619917 |
| 47 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.08046370 |
| 48 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.06242291 |
| 49 | Carbon metabolism_Homo sapiens_hsa01200 | 1.01172133 |
| 50 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.98542616 |
| 51 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.95700365 |
| 52 | Sulfur relay system_Homo sapiens_hsa04122 | 0.92443312 |
| 53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.88942508 |
| 54 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.81169772 |
| 55 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.77022960 |
| 56 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.74699492 |
| 57 | Lysine degradation_Homo sapiens_hsa00310 | 0.73924201 |
| 58 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.72089277 |
| 59 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.71210989 |
| 60 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.68468853 |
| 61 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.67418759 |
| 62 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.65077319 |
| 63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.64182378 |
| 64 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.64044307 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.64005388 |
| 66 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.58987284 |
| 67 | Prion diseases_Homo sapiens_hsa05020 | 0.43227795 |
| 68 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.40663560 |
| 69 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.38123597 |
| 70 | Metabolic pathways_Homo sapiens_hsa01100 | 0.37780893 |
| 71 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.32797860 |
| 72 | Lysosome_Homo sapiens_hsa04142 | 0.31319116 |
| 73 | Insulin resistance_Homo sapiens_hsa04931 | 0.29432860 |
| 74 | Galactose metabolism_Homo sapiens_hsa00052 | 0.28669531 |
| 75 | Pertussis_Homo sapiens_hsa05133 | 0.24034646 |
| 76 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.23701183 |
| 77 | Leishmaniasis_Homo sapiens_hsa05140 | 0.20941079 |
| 78 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.17469958 |
| 79 | Other glycan degradation_Homo sapiens_hsa00511 | 0.16867381 |
| 80 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.16828379 |
| 81 | Malaria_Homo sapiens_hsa05144 | 0.16605643 |
| 82 | Legionellosis_Homo sapiens_hsa05134 | 0.15920984 |
| 83 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.15637401 |
| 84 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.15111026 |
| 85 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.14286621 |
| 86 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.10836454 |
| 87 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.10092672 |
| 88 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.09747805 |
| 89 | Tuberculosis_Homo sapiens_hsa05152 | 0.09724744 |
| 90 | Phagosome_Homo sapiens_hsa04145 | 0.09630227 |
| 91 | Mineral absorption_Homo sapiens_hsa04978 | 0.07816325 |
| 92 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.05008710 |
| 93 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.02662996 |
| 94 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.00485501 |
| 95 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2069363 |
| 96 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1848660 |
| 97 | ECM-receptor interaction_Homo sapiens_hsa04512 | -0.1763731 |
| 98 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1738455 |
| 99 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1545798 |
| 100 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.1309181 |
| 101 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1032263 |
| 102 | Rheumatoid arthritis_Homo sapiens_hsa05323 | -0.0811072 |
| 103 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | -0.0785695 |
| 104 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0718892 |
| 105 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0569469 |
| 106 | Amoebiasis_Homo sapiens_hsa05146 | -0.0437859 |
| 107 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.0435466 |
| 108 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | -0.0400450 |
| 109 | Glucagon signaling pathway_Homo sapiens_hsa04922 | -0.0368894 |
| 110 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.0323467 |
| 111 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0301515 |
| 112 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.0284418 |
| 113 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0156151 |
| 114 | Hepatitis C_Homo sapiens_hsa05160 | -0.0124095 |
| 115 | Osteoclast differentiation_Homo sapiens_hsa04380 | -0.0023795 |
| 116 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0023471 |

